EhsanSadriMDFACS (He/Him)
[Pronunciation: essan ]
Ophthalmology • Newport Beach, CACornea & External Disease, Glaucoma Related, Oculo-Plastic & Orbital Reconstructive Surgery
Visionary Eye Institute
Dr. Sadri is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
361 Hospital Road
Suite 324
Newport Beach, CA 92663Phone+1 949-528-3608
Summary
- Dr. Ehsan Sadri is an ophthalmologist in Newport Beach, CA and is affiliated with multiple hospitals in the area, including AHMC Anaheim Regional Medical Center, Hoag Hospital - Irvine, Hoag Memorial Hospital Presbyterian, Providence Little Company of Mary Medical Center - Torrance, MemorialCare, Long Beach Memorial Medical Center, MemorialCare, Orange Coast Memorial Medical Center, Providence Little Company of Mary Medical Center San Pedro, and St. Mary Medical Center. He received his medical degree from University of Michigan Medical School and has been in practice 17 years. He also speaks multiple languages, including Spanish, French, and Farsi. He specializes in cornea & external disease, glaucoma related, and oculo-plastic & orbital reconstructive surgery and is experienced in sjogren's syndrome, blepharoplasty, glaucoma and related disorders, ophthalmic trauma, and refractive surgery.
Education & Training
University of MarylandResidency, Ophthalmology, 2001 - 2004
Arrowhead Regional Medical CenterInternship, Transitional Year, 2000 - 2001
University of Michigan Medical SchoolClass of 2000
Certifications & Licensure
CA State Medical License 2004 - 2026- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Fellow (FAAO) American Academy of Ophthalmology
Clinical Trials
- to Evaluate the Effectiveness and Safety of the Tixel® , VS LipiFlow® in the Treatment of Meibomian Gland Dysfunction Start of enrollment: 2022 Sep 19
- STREAMLINE®SURGICAL SYSTEM Compared to iStent Inject W® in Patients With Open-Angle Glaucoma Start of enrollment: 2022 Feb 09
- Treatment of Demodex Blepharitis With Ivermectin Gel 0.1% Plus Metronidazole 1% Start of enrollment: 2014 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- 19 citationsThe Prevalence ofBlepharitis in US Eye Care Clinic Patients as Determined by Collarettes: A Pathognomonic Sign.William Trattler, Paul Karpecki, Yuna Rapoport, Ehsan Sadri, Scott Schachter
Clinical Ophthalmology. 2022-01-01 - Surgical Outcomes, Ocular Safety and Tolerability of Bio-Interventional Cyclodialysis with Allograft Scleral Reinforcement: Clinical Experience of More than 240 Cases.Craig J Chaya, Leon W Herndon, Jorge Lince, Nathan Radcliffe, Ehsan Sadri
Journal of Clinical Medicine. 2024-08-06 - 25 citationsOnce daily dosing of bromfenac ophthalmic solution 0.09% for postoperative ocular inflammation and pain.Steven M Silverstein, Melissa G Cable, Ehsan Sadri, James H. Peace, Raymond Fong
Current Medical Research and Opinion. 2011-08-15
Authored Content
- The Prevalence of Demodex Blepharitis in US Eye Care Clinic Patients as Determined by Collarettes: A Pathognomonic SignJanuary 2022
Press Mentions
Multiple Surgeons to Present Data on Glaukos Technologies at 2019 American Society of Cataract and Refractive SurgeryMay 1st, 2019- Ophthalmology Technology Summit 2018 Poised to Foster New Breakthroughs and Valuable CollaborationsApril 30th, 2018
The Current Cataract Refractive LandscapeSeptember 20th, 2018
Research History
- Principle InvestigatorPresently conducting trials1995 - 2023
Professional Memberships
- Fellow
- Member
- Member
Other Languages
- Spanish, French, Farsi
Industry Relationships
- Consultant, AllerganDisclosure: Speaking
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
